29.7.2022
•
News
M&A
Tax
Advising Ronaldsay on the Sale of Hampshire Green Point
KSB's team (Dagmar Dubecká, Helena Navrátilová and Ján Béreš) advised Ronaldsay on the sale of Hampshire Green Point, which developed and commissioned the Green Point project, an energy-efficient eight-storey office building in Prague 5.
The building, which was completed last year, comprises approximately 7,000 sqm of office space and is BREEAM Excellent certified, which demonstrates its focus on efficiency and sustainability.
The building was sold to the WOOD & Company Office sub-fund, which focuses on office buildings in major cities in CEE countries. Green Point becomes the third Prague office building and the tenth office building in total held by the sub-fund.
More information is available here and here (only in Czech).
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
